AB

Afreen Bano

Active Director Director DIN 03485783
DIN 03485783 First appointment Jun 2011 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2011
Shareholding value •••• Premium profile

About Afreen Bano

Data last updated:

Afreen Bano is a Director at Sunlight Pharmaceuticals Private Limited (since 2011). The company operates in Trading. Sunlight Pharmaceuticals Private Limited reported revenue of ₹11.5 Lakh (FY 2025).

DIN 03485783
Primary Designation Director
Industry Trading
First Appointment 29 Jun 2011
Oldest Company Age 15 yrs
Largest company Sunlight Pharmaceuticals Private Limited · ₹11.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Jun 20112011₹11.5 Lakh (FY 2025)Active

Board colleagues of Afreen Bano

NameDINCompanyDesignation
Raja Israrali Rizvi03485343Sunlight Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sunlight Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Afreen Bano

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Afreen Bano

Afreen Bano currently holds 1 directorship: Sunlight Pharmaceuticals Private Limited (Director, since 29 Jun 2011, revenue ₹11.5 Lakh (FY 2025)).

Afreen Bano was first appointed on 29 Jun 2011 as Director at Sunlight Pharmaceuticals Private Limited.

The current boards of Afreen Bano's companies include Raja Israrali Rizvi (Sunlight Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available